☰

William F. Maragos - Publications

Affiliations: 
University of Kentucky, Lexington, KY 
Area:
Toxicology, Neuroscience Biology, Virology Biology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Schier CJ, Marks WD, Paris JJ, Barbour AJ, McLane VD, Maragos WF, McQuiston AR, Knapp PE, Hauser KF. Selective vulnerability of striatal D2 versus D1 dopamine receptor-expressing medium spiny neurons in HIV-1 Tat transgenic male mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28473642 DOI: 10.1523/Jneurosci.0622-17.2017  0.384
2015 Theodore S, Maragos W. 6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease. Immunopharmacology and Immunotoxicology. 37: 393-9. PMID 26211726 DOI: 10.3109/08923973.2015.1070172  0.717
2012 Theodore S, Cass WA, Dwoskin LP, Maragos WF. HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum. Synapse (New York, N.Y.). 66: 755-7. PMID 22517264 DOI: 10.1002/Syn.21564  0.755
2007 Theodore S, Cass WA, Nath A, Maragos WF. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Current Hiv Research. 5: 301-13. PMID 17504172 DOI: 10.2174/157016207780636515  0.745
2007 Hauser KF, El-Hage N, Stiene-Martin A, Maragos WF, Nath A, Persidsky Y, Volsky DJ, Knapp PE. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. Journal of Neurochemistry. 100: 567-86. PMID 17173547 DOI: 10.1111/J.1471-4159.2006.04227.X  0.477
2006 Berman JW, Carson MJ, Chang L, Cox BM, Fox HS, Gonzalez RG, Hanson GR, Hauser KF, Ho WZ, Hong JS, Major EO, Maragos WF, Masliah E, McArthur JC, Miller DB, et al. NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 351-99. PMID 18040811 DOI: 10.1007/S11481-006-9048-9  0.408
2006 Theodore S, Stolberg S, Cass WA, Maragos WF. Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Annals of the New York Academy of Sciences. 1074: 178-90. PMID 17105916 DOI: 10.1196/Annals.1369.018  0.775
2006 Theodore S, Cass WA, Nath A, Steiner J, Young K, Maragos WF. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Neurobiology of Disease. 23: 663-8. PMID 16828290 DOI: 10.1016/J.Nbd.2006.05.005  0.733
2006 Theodore S, Cass WA, Maragos WF. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum. Experimental Neurology. 199: 490-8. PMID 16510141 DOI: 10.1016/J.Expneurol.2006.01.009  0.768
2006 Theodore S, Cass WA, Maragos WF. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience. 137: 925-35. PMID 16338084 DOI: 10.1016/J.Neuroscience.2005.10.056  0.754
2005 Smith RR, Dimayuga ER, Keller JN, Maragos WF. Enhanced toxicity to the catecholamine tyramine in polyglutamine transfected SH-SY5Y cells. Neurochemical Research. 30: 527-31. PMID 16076022 DOI: 10.1007/S11064-005-2687-Z  0.403
2005 Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA. Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease. Molecular & Cellular Proteomics : McP. 4: 1849-61. PMID 15968004 DOI: 10.1074/Mcp.M500090-Mcp200  0.316
2004 Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC. Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochemical Research. 29: 741-6. PMID 15098936 DOI: 10.1023/B:Nere.0000018845.82808.45  0.444
2003 Cass WA, Harned ME, Peters LE, Nath A, Maragos WF. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Research. 984: 133-42. PMID 12932847 DOI: 10.1016/S0006-8993(03)03122-6  0.567
2003 Maragos WF, Rockich KT, Dean JJ, Young KL. Pre- or post-treatment with the mitochondrial uncoupler 2,4-dinitrophenol attenuates striatal quinolinate lesions. Brain Research. 966: 312-6. PMID 12618355 DOI: 10.1016/S0006-8993(02)04225-7  0.317
2003 Maragos WF, Tillman P, Jones M, Bruce-Keller AJ, Roth S, Bell JE, Nath A. Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat. Neuroscience. 117: 43-53. PMID 12605891 DOI: 10.1016/S0306-4522(02)00713-3  0.393
2003 Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M. Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Experimental Neurology. 179: 60-70. PMID 12504868 DOI: 10.1006/Exnr.2002.8048  0.484
2002 Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. Journal of Neurochemistry. 83: 955-63. PMID 12421368 DOI: 10.1046/J.1471-4159.2002.01212.X  0.602
2002 Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT. Molecular basis for interactions of HIV and drugs of abuse. Journal of Acquired Immune Deficiency Syndromes (1999). 31: S62-9. PMID 12394784 DOI: 10.1097/00126334-200210012-00006  0.336
2002 Flora G, Lee YW, Nath A, Maragos W, Hennig B, Toborek M. Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. Neuromolecular Medicine. 2: 71-85. PMID 12230306 DOI: 10.1385/Nmm:2:1:71  0.366
2002 Maragos WF, Zhu J, Chesnut MD, Dwoskin LP. Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes. Biochemical Pharmacology. 63: 1499-505. PMID 11996892 DOI: 10.1016/S0006-2952(02)00910-3  0.408
2001 Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR. Acceleration of HIV dementia with methamphetamine and cocaine. Journal of Neurovirology. 7: 66-71. PMID 11519485 DOI: 10.1080/135502801300069737  0.412
2001 Turchan J, Anderson C, Hauser KF, Sun Q, Zhang J, Liu Y, Wise PM, Kruman I, Maragos W, Mattson MP, Booze R, Nath A. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. Bmc Neuroscience. 2: 3. PMID 11252157 DOI: 10.1186/1471-2202-2-3  0.503
2000 Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. Journal of Psychopharmacology (Oxford, England). 14: 222-7. PMID 11106300 DOI: 10.1177/026988110001400305  0.56
2000 Keller JN, Huang FF, Dimayuga ER, Maragos WF. Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radical Biology & Medicine. 29: 1037-42. PMID 11084292 DOI: 10.1016/S0891-5849(00)00412-3  0.451
2000 Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Research. 879: 42-9. PMID 11011004 DOI: 10.1016/S0006-8993(00)02725-6  0.488
2000 Maragos WF, Jakel R, Chesnut D, Pocernich CB, Butterfield DA, St Clair D, Cass WA. Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Research. 878: 218-22. PMID 10996156 DOI: 10.1016/S0006-8993(00)02707-4  0.391
2000 Jakel RJ, Maragos WF. Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends in Neurosciences. 23: 239-45. PMID 10838590 DOI: 10.1016/S0166-2236(00)01568-X  0.409
1999 Maragos WF, Jakel RJ, Chesnut MD, Geddes JW, Dwoskin LP. Does dopamine contribute to striatal damage caused by impaired mitochondrial function? Annals of the New York Academy of Sciences. 893: 345-9. PMID 10672263 DOI: 10.1111/J.1749-6632.1999.Tb07851.X  0.445
1999 Maragos WF, Tillman PA, Chesnut MD, Jakel RJ. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions. Brain Research. 834: 168-72. PMID 10407109 DOI: 10.1016/S0006-8993(99)01487-0  0.399
1999 Kruman II, Nath A, Maragos WF, Chan SL, Jones M, Rangnekar VM, Jakel RJ, Mattson MP. Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. The American Journal of Pathology. 155: 39-46. PMID 10393834 DOI: 10.1016/S0002-9440(10)65096-1  0.481
1998 Maragos WF, Jakel RJ, Pang Z, Geddes JW. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions. Experimental Neurology. 154: 637-44. PMID 9878198 DOI: 10.1006/Exnr.1998.6918  0.433
1995 Maragos WF, Silverstein FS. Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats. Journal of Neurochemistry. 64: 2362-5. PMID 7536812 DOI: 10.1046/J.1471-4159.1995.64052362.X  0.306
Show low-probability matches.